IGNACIO
RODRÍGUEZ RAMÍREZ DE ARELLANO
Profesor contratado doctor
![Foto de IGNACIO](/img/nophoto.png)
![Foto de Centro Nacional de Investigaciones Cardiovasculares Carlos III](/img/noimage_org.png)
Centro Nacional de Investigaciones Cardiovasculares Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro Nacional de Investigaciones Cardiovasculares Carlos III (6)
2023
-
Corrigendum: Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model (Frontiers in Pharmacology, (2023), 14, (1021535), 10.3389/fphar.2023.1021535)
Frontiers in Pharmacology
-
Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model
Frontiers in Pharmacology, Vol. 14
2021
-
HAP-Multitag, a PET and Positive MRI Contrast Nanotracer for the Longitudinal Characterization of Vascular Calcifications in Atherosclerosis
ACS Applied Materials and Interfaces, Vol. 13, Núm. 38, pp. 45279-45290
2019
-
Long-Term Dabigatran Treatment Delays Alzheimer's Disease Pathogenesis in the TgCRND8 Mouse Model
Journal of the American College of Cardiology, Vol. 74, Núm. 15, pp. 1910-1923
2017
-
Iron oxide nanoparticle-based MRI contrast agents: Characterization and in vivo use
Magnetic Characterization Techniques for Nanomaterials (Springer Berlin Heidelberg), pp. 85-120
2012
-
Apparent diffusion coefficient of hyperpolarized 3He with minimal influence of the residual gas in small animals
NMR in Biomedicine, Vol. 25, Núm. 9, pp. 1026-1032